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The following text from the original article was incorrect:
The authors speculate that LAT hypopalmitoylation could result from a defect in one of the recently identified murine
palmitoyl acyl transferases (PATs), which can display specificity for the addition of palmitate to substrates. This model
is a more likely candidate than an increase in LAT depalmitoylation by the only known cytoplasmic palmitoyl protein
thioesterase APT1, an enzyme that has an apparent broad substrate specificity.
The correct text is as follows:
The authors speculate that it could be a defect in LAT palmitoylation by the only known cytoplasmic palmitoyl protein
thioesterase APT1, an enzyme that has broad substrate specificity but no global defect in ionomycin-treated T cells.
The authors regret the error.
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